跳至主要内容
临床试验/NCT02479165
NCT02479165已完成4 期

Pain Management After Cardiac Surgery - Opioids or NSAID? A Randomized Prospective Study

Aalborg University Hospital0 个研究点目标入组 182 人开始时间: 2009年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
182
主要终点
Pain score - Visual Analouge Scale

研究概览

简要总结

The aim of this randomized controlled study is to shed light on the analgesic properties and side-effect profile of an opiod-based regimen as opposed to an Ibuprofene based regimen.

详细描述

Background:

Postoperative pain following median sternotomy can represent a major postoperative problem as it can lead to reduced mobilization and shallow, restricted breathing and insufficient cough, which can lead to pulmonary complications.

However, pain management with opioids has frequent side-effects such as confusion, respiratory depression, sedation, nausea and obstipation/ paralytic ilieus. Non-steroid anti-inflammatory drugs (NSAIDs) can been used as opiod-sparing analgesics following cardiac surgery. However, this remains controversial, as NSAIDs has been linked to an increased risk of myocardial infarction, especially in patients with ischaemic heart disease, renal failure, gastrointestinal bleeding, and possibly impaired sternal healing.

The investigators wanted to investigate the analgesic properties of a opiod-based regimen with that of an ibuprofene-based, through randomization of patients to one of the two arms.

Intervention:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Cardiac surgery through median sternotomy
  • Written consent
  • Age over 18 years

排除标准

  • Other forms of sternotomy (i.e. re-sternotomy or partial sternotomy)
  • Preoperative creatinine over 110 µmol/L
  • Preoperative use of opioids or NSAIDs in analgesic doses (aspirin in antithrombotic doses was accepted)
  • Allergy to NSAIDs or opioids, and other contraindications to the used drugs
  • The postoperative exclusion criteria were:
  • Staying more than one night at the intensive care unit
  • Unacceptable side effects
  • Exclusion at the patients request

研究组 & 干预措施

Opioid group

Active Comparator

If randomized to the opiod group, the patient was given the following regimen for 1 week, upon return from the intensive care unit, after surgery.

Tbl. Oxycodone (slow-release) 10mg, Twice daily for 1 week Tbl. Paracetamol 1000mg, Four times daily for 1 week Tbl.oxycodone 5mg Max 4 times daily, as needed, until discharge. Inj, oxycodone 2.5 mg, Max 4 times daily, as needed, until discharge Tbl. Magnesia 1g, Twice daily, for 1 week Sol. Sodiumpicosulfate 7.5mg/ml 10 drops daily, for 1 week

干预措施: Oxycodone (Drug)

Ibuprofene group

Active Comparator

If randomized to the ibuprofen group, the patient was given the following regimen for 1 week, upon return from the intensive care unit, after surgery.

Tbl. Ibuprofen (slow-release) 800mg, Twice daily, for 1 week Tbl. Paracetamol 1000mg, Four times daily, for 1 week Tbl.oxycodone 5mg Max 4 times daily, as needed. Until discharge. Inj, oxycodone 2.5 mg Max 4 times daily, as needed. Until discharge. Tbl. Lanzoprazole 40 mg, Once daily, for 1 week Tbl. Magnesia 1g, Twice daily, for 1 week Sol. Sodiumpicosulfate 7.5mg/ml, 10 drops daily, for 1 week

干预措施: Ibuprofene (Drug)

结局指标

主要结局

Pain score - Visual Analouge Scale

时间窗: 5 days

Visual analouge scale from 0-10, recorded at noon every day. Given as average/minimum/maximum previous 24h by patient. Until discharge, average 5th postoperative day.

次要结局

  • Nausea, Hours(5 days)
  • Vomiting, events pr. 24 hours(5 days.)
  • Myocardial Infarction, no. of cases(36 months)
  • All cause mortality(36 months)
  • Gastro-intestinal bleeding, no. of cases(36 months)
  • Degree of mobilization, Mobilization scale(5 days)
  • Bowel movement, hours until movement(5 days)
  • Opioid antidote(5 days)
  • Renal function as serum-creatinine (micromol/l)(36 months)
  • Hallucination, events pr. 24 hours(5 days)
  • Sternal non-union, no of cases(36 months)
  • Confusion(5 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Martin Agge Nørgaard

MD, DMsc

Aalborg University Hospital

相似试验